1. |
秦桂璽.中毒. 見: 葉任高, 等. 主編. 內科學. 第6版. 北京: 人民衛生出版社; 2004. 948~991.
|
2. |
Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev, 2003; 22(3): 165–190.
|
3. |
Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM, 2000; 93(11): 715–731.
|
4. |
Qin GX. Poisoning. In: Ye RG, et al. Editor-in-chief. Internal Medicine. 6th ed. Beijing: People’s Medical Publishing House; 2004. 948–991.
|
5. |
Guyatt GH, R ennie D, Editors. The Evidence-Based Medicine Working Group. Users’ Guides to the Medical L iterature: A Mannual for Evidence-Based Clinical Practice. Chicago: AMA Press; 2002.
|
6. |
Phillips B, Ball C, Sackett D, et al. Levels of evidence and grades of recommendation. Available for URL: http://www.cebm.net.
|
7. |
Buckley NA, Eddleston M, Szinicz L. Oximes for acute organophosphate pesticide poisoning. The Cochrane Database of Systematic Reviews, 2005, Issue 1.
|
8. |
John P, John M, Petra G. Oxime therapy and outcomes in human organophosphate poisoning: An evaluation using meta-analytic techniques. Crit Care Med, 2006; 34(2): 502–510.
|
9. |
Johnson S, Peter JV, Thomas K, et al. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus vs 12 gm infusion) in the management of organophosphorus poisoning. A randomized, double blind controlled clinical trial. J Assoc Physicians India, 1996; 44(8): 529–531.
|
10. |
Cherian AM, Peter JV, Samuel J, et al. Effectiveness of P2AM (PAM–Pralidoxime) in the treatment of organophosphate poisoning (OPP). A randomized, double blind placebo controlled clinical trial. J Assoc Physicians India, 1997; 45: 22–24.
|
11. |
Cherian MA, Roshini C, Visalakshi J, et al. Biochemical and clinical profile after organophosphate poisoning-A placebo-controlled trial using pralidoxime. J Assoc Physicians India, 2005; 53: 427–431.
|
12. |
de Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet, 1992; 339(8802): 1136–1138.
|
13. |
Balali-Mood M, Shariat M.Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effect of oximes. J Physiol Paris, 1998; 92(5-6): 375–378.
|
14. |
Abdollahi M, Jafari A, Jalali N, et al. A new approach to the efficacy of oximes in the management of acute organophosphorus poisoning. Ir J Med Sci, 1995; 20: 105–109.
|
15. |
Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care (London), 2001; 5(4): 211–215.15 Medicis JJ, Stork CM, Howland MA, et al. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. J Toxicol Clin Toxicol, 1996; 34(3): 289–295.
|
16. |
Xue SZ, Ding XJ, Ding Y. Clinical observation and comparison of the effectiveness of several oxime cholinesterase reactivators. Scan J Work Environ Health, 1985; 11(Suppl 4): 46–48.
|
17. |
Taylor P. Anticholinesterase agents. In: Gilman AG, Goodman LS, Rall TW, et al. The Pharmacological Basis of Therapeutics. New York, Macmillan;1985. 122.
|